Understanding and navigating insurance access can be daunting. That’s why PPMD kicked off a new webinar series, “Advocating for Access,” earlier this week with its first monthly installment on Navigating Approved Therapies in Duchenne.
PPMD’s Rachel Schrader, VP of Clinical Care and Education, opened the webinar, outlining PPMD’s plans to partner with the community to provide comprehensive, wrap-around support and resources direct to families. Kelly Maynard, President of Little Hercules Foundation and Co-Founder of the Duchenne Family Assistance Program, alongside PPMD’s Brian Denger, Community Engagement Coordinator, then provided an overview of how PPMD and the Little Hercules Team have partnered together to provide comprehensive, individualized support to families navigating access to therapies.
We also heard from Dr. Aravindhan Veerapandiyan, Director of the Certified Duchenne Care Center at Arkansas Children’s Hospital, about how clinicians and clinic teams are critical to promoting access to approved therapies. Dr. Veerapandiyan is leading efforts in the creation of a physician consensus statement around access to approved drugs.
Looking for more? Check out PPMD’s Access and Coverage Resources for New Therapies, which includes a library of resources to help you navigate insurance and your benefits.Access & Coverage Resources for New Therapies
You can also schedule time with Brian directly through our PPMD For You platform, or email the Duchenne Family Assistance Program at firstname.lastname@example.org. And, as always, if you have other questions, send them our way! Your questions are always welcome at email@example.com.PPMD for You
We hope to see you September 28, 2023 for our next monthly Advocating for Access webinar installment, always the fourth Thursday of the month at 1:00pm ET. Have a topic you want us to explore? Send your ideas and questions to firstname.lastname@example.org.